Summit is a UK based drug discovery and development Company focused on producing innovative medicines to treat areas of high unmet medical need. Summit is developing high-quality, differentiated programmes that seek to provide the Company with the opportunity of maximising their therapeutic and commercial potential for the benefit of patients and shareholders.Summit’s current therapeutic focus is on the rare disease Duchenne Muscular Dystrophy (DMD) and the infectious disease caused by the bacteria C. difficile.